Physician profile
Emily Bernstein
NPI 1205962149
$2,124.21
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $326 · 2021: $153 · 2022: $163 · 2023: $828 · 2024: $19.47 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.79 | 2021-2024 | Vraylar |
| Corium, LLC | $235.31 | 2022-2023 | Azstarys |
| Axsome Therapeutics, INC. | $228.92 | 2022-2025 | Auvelity |
| Lundbeck LLC | $225.22 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $215.18 | 2019-2023 | Rexulti |
| Neurocrine Biosciences, INC. | $202.90 | 2019-2023 | Ingrezza |
| Allergan, INC. | $177.52 | 2019-2020 | |
| Alkermes, INC. | $122.74 | 2022-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.04 | 2021-2023 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $89.12 | 2019-2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $68.08 | 2019-2023 | Spravato |
| Sunovion Pharmaceuticals INC. | $53.81 | 2019 | |
| Vanda Pharmaceuticals INC. | $47.70 | 2019 | |
| Shire North American Group INC | $22.91 | 2019 | |
| Adlon Therapeutics L.P. | $20.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $13.42 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.